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Background: Several local studies showed that the 2009 influenza pandemic delayed
the RSV season. However, no global-level analyses are available on the possible
impact of the 2009 influenza pandemic on the RSV season.
Objectives: We aim to understand the impact of the 2009 influenza pandemic on the
RSV season.
Methods: We compiled data from published literature (through a systematic review),
online reports/datasets and previously published data on global RSV seasonality and
conducted a global-level systematic analysis on the impact of the 2009 influenza
pandemic on RSV seasonality.
Results: We included 354 seasons of 45 unique sites, from 26 countries. Globally,
the influenza pandemic delayed the onset of the first RSV season by 0.58 months on
average (95% CI: 0.42, 0.73; maximum delay: 2.5 months) and the onset of the sec-
ond RSV season by a lesser extent (0.25 months; 95% CI: 0.12, 0.39; maximum delay:
3.4 months); no delayed onset was observed for the third RSV season. The delayed
onset was most pronounced in the northern temperate, followed by the southern
temperate, and was least pronounced in the tropics.
Conclusions: The 2009 influenza pandemic delayed the RSV onset on average by
0.58 months and up to 2.5 months. This suggests evidence of viral interference as well
as the impact of public health measures and has important implications for prepared-
ness for RSV season during the ongoing COVID-19 pandemic and future pandemics.
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1 | INTRODUCTION
Respiratory syncytial virus (RSV) is the most common pathogen
identified in young children with acute lower respiratory infec-
tions1,2 and poses a major burden on hospital beds during the peak
of RSV transmission. RSV activity has clear seasonality in most
parts of the world; RSV season, usually defined as a particular
period of time with high RSV activity above a certain threshold,
typically starts in late autumn and early winter in temperate regions
and lasts for about 5 months.3 RSV seasonality information is
important for health services planning as well as the timing of RSV
passive prophylaxis.
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The pandemic influenza H1N1 2009 virus was first detected in
the United States in April 2009. It quickly spread globally since then,
and the World Health Organisation (WHO) declared a pandemic in
June 2009.4 In August 2010, WHO declared the end of the influenza
pandemic.5
Several local reports from China,6–8 France,9 Germany10 and
Israel11,12 showed that the 2009 influenza pandemic delayed the RSV
season by several weeks, whereas a study from Spain did not observe
any differences in RSV season between the pandemic and the pre-
pandemic period (a summary of these reports is available in Table S1).
However, no global-level analyses are available. In the present study,
we complied data from published literatures, online reports/datasets
and previously published data on global RSV seasonality3 and con-
ducted a global-level systematic analysis on the impact of the 2009
influenza pandemic on RSV seasonality.
2 | METHODS
2.1 | Definitions
Based on whether an RSV season occurred during the 2009 influenza
pandemic, we categorised RSV seasons into four different periods:
pre-pandemic, pandemic (1st RSV season), pandemic (2nd RSV sea-
son) and post-pandemic. An RSV season was grouped into pre-
pandemic period if the entire season occurred before April 2009. An
RSV season was grouped into pandemic (1st RSV season), if it was the
first RSV season since April 2009 and was grouped into pandemic
(2nd RSV season), if it was the second RSV season since April 2009.
Lastly, an RSV season was grouped into post-pandemic period if it
was the 3rd or later RSV season since April 2009.
2.2 | Data source
We collected RSV seasonality results (e.g. onset, offset, peak and
duration of RSV season) and RSV seasonality data (e.g. weekly or
monthly counts of laboratory-confirmed RSV infection) from the liter-
ature via a systematic literature review, online datasets/reports and
previously published data on global RSV seasonality.3 The following
eligibility criteria were applied for the selection process.
2.2.1 | Inclusion criteria
• Studies reporting laboratory-confirmed incidence data of human
infection of RSV.
• RSV seasonality results or RSV seasonality data should be extract-
able for the pandemic (1st RSV season) period as defined above,
plus at least 1 year in pre- or post-pandemic period.
• Studies should be able to test RSV year-round (e.g. not just during
influenza seasons) and should report at least 25 positive RSV cases
per year.3
• For studies that reported RSV seasonality data, the data should be
made available at least on a monthly basis.
2.2.2 | Exclusion criteria
• Studies reporting respiratory infections only among those with
special medical conditions (e.g. patients with chronic obstructive
pulmonary disease or patients infected with human immunodefi-
ciency virus).
• Studies only reporting nosocomial infections.
2.2.3 | Systematic literature review
A systematic literature review (PROSPERO registry number:
CRD42021239011) was conducted. We searched three databases,
Medline (Ovid), Embase (Ovid) and Global Health (Ovid) for any publi-
cations between 2009 and 2020 that potentially fulfilled the selection
criteria above. The detailed search strategy can be found in Text S1.
Publications in any languages were considered for eligibility. The liter-
ature search and screening (including title and abstract screening and
full-text screening) were conducted by two reviewers Y. L. and T. M.,
independently, with inconsistencies resolved through discussion
among the review team. For data extraction, we used a standard data
extraction form, modified based on our previous global seasonality of
respiratory viruses study.3 The data extraction form collected informa-
tion on study sites, period, subjects, case definition, clinical specimens,
RSV testing method, RSV seasonality results (including onset, offset,
peak and duration as per reported in the literature) and RSV seasonal-
ity data (e.g. weekly or monthly counts of RSV positives). The data
extraction was conducted independently by T. M. and jointly by
X. W., F. d. W. and J. M. Where any inconsistencies occurred, a final
decision was made by Y. L.
2.2.4 | Additional data
We extracted RSV activity data from three online datasets/reports
from the FluWatch programme in Canada,13 the Infectious Agents
Surveillance Report in Japan14 and the Virology Annual Report in
New Zealand15 between 2000 and 2019. No RSV data were extracted
for 2020 considering the impact of COVID-19 on RSV seasonality.
We also included RSV activity data from our previously published
review on global RSV seasonality.3
2.3 | Quality assessment
For each included record, two reviewers (X. W. and T. M.) conducted
quality assessment independently using a modified questionnaire
based on our previous study.3 Briefly, the questionnaire comprised
three brief questions regarding data representativeness, diagnostic
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practices and timely reporting; for each question, each study was
rated from A (very good) to D (bad). Studies with any ‘D’ ratings were
excluded from the analysis and studies with any ‘C’ ratings were
excluded from the sensitivity analysis that is described in the next
section. Details of the questionnaire are available in Text S2.
2.4 | Data analysis
For those studies/reports/datasets that had RSV seasonality data
(e.g. weekly/monthly counts of RSV positives), we determined the
RSV seasonality results using the following approach: we first divided
the timeline into 12-month intervals so that each interval had a com-
plete RSV season; for each of the weeks/months per interval, we then
calculated the annual cumulative proportion (ACP), which ranged 0–1.
The ACP of the last week/month of the interval should be 1. Based
on ACP, RSV onset was defined as the week/month with ACP being
0.1, and RSV offset was defined as the week/month with ACP
being 0.9. Linear interpolation was applied to allow for non-integer
results for RSV onset/offset (e.g. RSV onset could be month 1.2 or
week 5.5 rather than month 1 or week 6). RSV duration was defined
as the difference between RSV onset and offset. RSV peak was
defined as the week/month with the highest RSV counts in each
12-month interval.
For those studies that reported RSV seasonality results
(e.g. onset, offset, peak and duration of RSV season), we used the
extracted results for our data analysis. If studies had both RSV season-
ality results and RSV seasonality data, we prioritised the inclusion of
RSV seasonality data in our main analysis and prioritised the inclusion
of RSV seasonality results in our sensitivity analysis. Where available,
we calculated the time interval between onset and peak as an addi-
tional measure of interest.
Our primary outcome of interest, determined a priori, was the
difference in RSV onset between the first RSV season in the
pandemic and RSV seasons during the inter-pandemic period
(i.e. pre-pandemic and post-pandemic). Secondary outcomes of inter-
est included the difference in RSV offset, peak, duration and onset-
to-peak interval between the first RSV season in the pandemic and
the inter-pandemic period. The same comparisons as described above
were repeated between the second RSV season since the pandemic
and the inter-pandemic period. An ad hoc analysis was also
conducted to compare the difference in RSV onset between the third
RSV season since the pandemic and the inter-pandemic period.
Subgroup analysis that separated pre- and post-pandemic periods
was also conducted. Based on the quality assessment results, we
conducted a sensitivity analysis that excluded studies with ‘C’ ratings
in any of the questions. We also conducted a sensitivity analysis that
excluded studies reporting less than five RSV seasons. As an explor-
atory analysis, we compared the time length required to reach differ-
ent levels of ACP between the pandemic and inter-pandemic periods,
by using seasonality data. This would help examine the impact of the
influenza pandemic on RSV activity over the complete course of one
RSV season.
Moreover, as latitude played an important role in RSV
seasonality,3 we conducted stratified analysis by three latitude group-
ings: northern temperate (>23.44 degrees), tropics (between 23.44
and 23.44 degrees) and southern temperate (<23.44 degrees).
All data analyses and visualisations were conducted using the R
software (version 3.6.2).
3 | RESULTS
As shown in Figure 1, we screened 1792 records by title and abstract
and 259 records by full-text, which led to the inclusion of 32 studies
from the literature review. In addition, we included three more
records from online datasets/reports and eight more records from
previously published data on global RSV seasonality,3 bringing the
total number of included records to 43. These 43 records provided
data on 354 seasons for 45 unique sites (48 sites in total), from
26 countries. More detailed information on the included records is
presented in Table S2.
Overall, we found that the influenza pandemic delayed the
onset of the first RSV season by 0.58 months (95% CI: 0.42, 0.73) on
average, with a maximum delay of 2.5 months. By comparison, the
influenza pandemic delayed the onset of the second RSV season by a
lesser extent, which was 0.25 months (95% CI: 0.12, 0.39), with
a maximum delay of 3.4 months. RSV seasons during the pandemic
were found to be shorter, and the interval between onset and peak
was also shorter (Table 1). Similar findings were observed in the
sensitivity analyses that prioritised the inclusion of seasonality
results (Table S3); excluded studies with any ‘C’ ratings (Table S4);
and excluded studies with less than five RSV seasons (Table S5). The
above findings did not change substantively when only including
the pre-pandemic period or when only including the post-pandemic
period. In the ad hoc analysis that assessed the third RSV season
(since the influenza pandemic), we did not observe a statistically
significant delay in the RSV season onset (95% CI: 0.33, 0.04).
Some regional variations in the effects of the influenza
pandemic on RSV seasonality were noted, as shown in Figure 2 and
Figures S1–S4. For the first RSV season of the pandemic, the delay in
RSV onset and peak was more pronounced in the northern temperate,
whereas the delay in RSV offset was more pronounced in the south-
ern temperate; no statistically significant findings were observed in
the tropics where RSV activity was seasonal (Table 2). For the second
RSV season of the pandemic, interestingly, we found that the RSV
season ended earlier in the southern temperate, opposite from what
was observed in the northern temperate; no statistically significant
findings were observed in the tropics (Table 2).
The results of our exploratory analysis using only the RSV season-
ality data confirmed the regional variations observed above but pro-
vided more details (Figure 3): in the northern temperate, the delay in
observing the same level of cumulative RSV activity was most pro-
nounced at the beginning of both the first and second RSV seasons
since the pandemic, but the delay became less pronounced over the
course of the season, and there was almost no delay at the season
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offset; in the southern temperate, a pronounced delay (0.38 months,
95% CI: 0.14, 0.61) was observed around the offset for the first RSV
season and an advanced RSV epidemic (0.29 months, 95% CI:
0.63, 0.04) was observed around the offset for the second RSV
season, though not being statistically significant.
4 | DISCUSSION
In this study, we highlighted a globally averaged delay of 0.58 months
and a maximum delay of 2.5 months in the onset of the first RSV
season in the influenza pandemic compared with the inter-pandemic
period. The delayed onset was most pronounced in the northern
temperate, followed by the southern temperate, and was least
pronounced in the tropics. The second RSV season was impacted to a
lesser extent, and the third RSV season was not impacted.
Our findings suggest the presence of viral interference and poten-
tially have important implications for preparedness for RSV season in
the ongoing COVID-19 pandemic, although there are differences
worth noting between the 2009 influenza pandemic and the COVID-
19 pandemic. First, the viral pathogens causing the pandemic are dif-
ferent (i.e. influenza H1N1pdm vs. SARS-CoV-2) and viral interference
effects could differ by viruses pair.16 Second, unlike during the
COVID-19 pandemic, no extensive non-pharmaceutical interventions
such as nationwide lockdowns were implemented during the influenza
pandemic, although certain restrictions such as school closures and
international travel limits were introduced by some countries.17 This
could help explain why the RSV onset was delayed by several months
in some countries in the southern hemisphere in 2020,18,19 rather
than a few weeks in the 2009 influenza pandemic as shown in our
study. We also observed a shorter interval between RSV onset and
peak in both the first and second seasons after the 2009 influenza
pandemic, which possibly indicates that the post-COVID-19 RSV sea-
son might reach its peak earlier once it starts. Interestingly, compared
with RSV, the circulation of human rhinovirus was less impacted by
either the 2009 influenza pandemic9,10 or the ongoing COVID-19
pandemic,20,21 which in turn supported the role of viral interference in
the delayed RSV season although the typical age profile of infections
F I G UR E 1 Flowchart presenting
study selection process
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differed among influenza, RSV, rhinovirus and SARS-CoV-2. In the
present study, we found that the influenza pandemic affected the
second RSV season to a lesser extent and that RSV season tended to
revert to the pre-pandemic state. This could provide clues for the
timing of the second RSV season after the resumption of RSV activity
in the COVID-19 pandemic if no further major non-pharmaceutical
interventions are implemented.
Our findings also highlighted the regional variations in the effect
of the influenza pandemic on RSV seasonality. We believe these
variations could be explained by the timing of the emergence of the
pandemic relative to the timing of the local RSV season. For example,
we found that in the southern temperate, the onset of the RSV season
was less affected compared with the offset of the RSV season. This
was because RSV season in the southern temperate usually began in
May and June, which were the months when the influenza pandemic
just started in 2009. By comparison, we found that the onset of the
RSV season was more affected compared with the offset of the RSV
season in the northern temperate. This was because RSV season
usually began in November and December in the northern temperate,
by which time the influenza pandemic had already unfolded. For the
F I GU R E 2 Comparison of RSV onset between 2009 influenza pandemic and inter-pandemic periods by study site. Reference is pre/post-
pandemic period. Pandemic (1st season) is defined as the first RSV season since April 2009. Pandemic (2nd season) is defined as the second RSV
season since April 2009
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tropics, however, we did not observe any statistically significant
differences between RSV seasons in the pandemic and in the inter-
pandemic period, although the point estimates indicated that the RSV
season might be delayed. This could be due to the lack of statistical
power because the majority of the data were from temperate regions.
This could also be due to the fact that the timing of RSV season was
more varied in the tropics than the temperate regions.3
Our study has several strengths. First, we went beyond published
literatures that reported the impact of the influenza pandemic on RSV
seasonality (as summarised in Table S1), by compiling both RSV
seasonality results and RSV seasonality data from various sources.
This allowed us to analyse the best available data and helps reduce
publication bias that tended to favour statistically significant results.
Second, while focusing on RSV onset as the main outcome measure,
we conducted several exploratory analyses to assess other measures
of RSV season, such as peak, onset-peak interval, offset and duration,
as well as a novel measure that assessed the time length required to
reach different levels of cumulative RSV activity. Third, we conducted
several sets of subgroup analyses, for example, by latitude, to gain
more insights into the regional-specific impact of the influenza pan-
demic on RSV seasonality. However, we do acknowledge some limita-
tions of our study. First, the underlying methodology of our compiled
data varied greatly; nonetheless, because the comparisons between
the pandemic and inter-pandemic periods were made only within each
site (i.e. site-wise comparison), we do not expect our results to be
affected substantially. Second, we were unable to assess any age-
specific effects of the influenza pandemic on RSV seasonality due to
the lack of age-disaggregated data. Third, we acknowledge that test-
ing practice and method in each study site could change substantially
over time, especially during and after the 2009 influenza pandemic;
nonetheless, our subgroup analysis excluding the pre-pandemic period
showed similar results. Fourth, most of the study sites (31/48, 65%)
were from northern hemisphere, and as a result, the global overall
results were largely represented by northern hemisphere; in particular,
we might lack the statistical power to differentiate the true impact of
the influenza pandemic from the typical variations in the timing
of RSV season for the tropics and southern hemisphere. Fifth, we
were unable to compare the amplitude of RSV peak across different
seasons due to the perceived change over time in the testing capacity.
A recent modelling study by Baker and colleagues22 predicts that non-
pharmaceutical interventions could lead to larger future outbreaks in
the second RSV season after the COVID-19 pandemic (i.e. the year
2021), although that study did not account for viral interference in
the model. Lastly, our results should be interpreted in the context of
the differences, as noted above, between the 2009 influenza pan-
demic and the ongoing COVID-19 pandemic.
RSV seasonality information is important for both public health
services planning and timely administration of RSV prophylaxis. The
experience from the 2009 influenza pandemic could potentially help
prepare for the upcoming RSV season during the ongoing COVID-19
pandemic and any possible future pandemics. RSV surveillance across
multiple sites globally was interrupted during the COVID-19 pan-
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understand the full profile of RSV epidemiology in the post-
COVID-19 era.
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